Ziegler Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-149,041
Closed -$5.51M 390
2022
Q1
$5.51M Sell
149,041
-1,972
-1% -$76.9K 0.23% 150
2021
Q4
$6.87M Sell
151,013
-3,333
-2% -$174K 0.25% 149
2021
Q3
$9.78M Buy
154,346
+92,286
+149% +$7.03M 0.35% 109
2021
Q2
$14.3M Sell
62,060
-97,832
-61% -$7.78M 0.48% 61
2021
Q1
$10.9M Sell
159,892
-72,403
-31% -$5.62M 0.34% 109
2020
Q4
$16.8M Buy
232,295
+4,109
+2% +$238K 0.56% 44
2020
Q3
$8.66M Sell
228,186
-112,136
-33% -$3.79M 0.33% 90
2020
Q2
$12.1M Sell
340,322
-20,105
-6% -$572K 0.38% 72
2020
Q1
$7.87M Buy
+360,427
New +$8.08M 0.21% 136

Other funds holding CDNA

Ziegler Capital Management's CDNA Position: Q2 2022 in Review

Ziegler Capital Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 149,041 shares — an estimated $5.51M sold.

Ziegler Capital Management first reported a position in CDNA in Q1 2020 and held it in 9 quarters. The position peaked at $16.8M in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Ziegler Capital Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Ziegler Capital Management sold 149,041 CareDx shares in Q2 2022, an estimated $5.51M.
  • Ziegler Capital Management first reported a position in CareDx in Q1 2020 and held it in 9 quarters.
  • Ziegler Capital Management's CareDx position peaked at $16.8M in Q4 2020.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Ziegler Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.